Literature DB >> 6207684

High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions.

K J Kwon-Chung, J E Bennett.   

Abstract

The global distribution of 96 clinical isolates of Cryptococcus neoformans var. gattii among a total of 725 C. neoformans isolates was investigated. While C. neoformans var. gattii was not found among isolates obtained from Europe (excluding the United Kingdom) and Japan; and it was found only infrequently in North America (excluding Southern California), the United Kingdom, New Zealand, and Argentina; the variety was prevalent in regions with tropical to subtropical climates such as South East Asia, Southern California, Brazil, Mid to South Pacific, and the central part of Africa. Among the isolates of C. neoformans var. gattii in our collection, serotype B predominanted (77 of 96), and the serotype C isolates were almost exclusively from North America.

Entities:  

Mesh：

Year:  1984        PMID： 6207684

Source DB:  PubMed          Journal:  Zentralbl Bakteriol Mikrobiol Hyg A        ISSN： 0176-6724


  44 in total

1.  Serotyping of Cryptococcus neoformans strains isolated from clinical specimens in Thailand and their susceptibility to various antifungal agents.

Authors:  N Poonwan; Y Mikami; S Poosuwan; J Boon-Long; N Mekha; M Kusum; K Yazawa; R Tanaka; K Nishimura; K Konyama
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

2.  Cryptococcus gattii genotype VGI infection in New England.

Authors:  Russell J McCulloh; Raina Phillips; John R Perfect; Edmond J Byrnes; Joseph Heitman; Elizabeth Dufort
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

3.  Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC.

Authors:  R A Fromtling; G K Abruzzo; G S Bulmer
Journal:  Mycopathologia       Date:  1986-04       Impact factor: 2.574

4.  Characterization of environmental sources of the human and animal pathogen Cryptococcus gattii in British Columbia, Canada, and the Pacific Northwest of the United States.

Authors:  Sarah E Kidd; Yat Chow; Sunny Mak; Paxton J Bach; Huiming Chen; Adrian O Hingston; James W Kronstad; Karen H Bartlett
Journal:  Appl Environ Microbiol       Date:  2006-12-28       Impact factor: 4.792

5.  Cryptococcus gattii, no longer an accidental pathogen?

Authors:  Deborah J Springer; Sujal Phadke; Blake Billmyre; Joseph Heitman
Journal:  Curr Fungal Infect Rep       Date:  2012-12

6.  CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence.

Authors:  Mairi C Noverr; Peter R Williamson; Ryan S Fajardo; Gary B Huffnagle
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

7.  Cryptococcus gattii outbreak expands into the Northwestern United States with fatal consequences.

Authors:  Edmond J Byrnes; Joseph Heitman
Journal:  F1000 Biol Rep       Date:  2009-08-17

8.  Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA.

Authors:  Laura MacDougall; Sarah E Kidd; Eleni Galanis; Sunny Mak; Mira J Leslie; Paul R Cieslak; James W Kronstad; Muhammad G Morshed; Karen H Bartlett
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

9.  Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States.

Authors:  Edmond J Byrnes; Wenjun Li; Yonathan Lewit; Hansong Ma; Kerstin Voelz; Ping Ren; Dee A Carter; Vishnu Chaturvedi; Robert J Bildfell; Robin C May; Joseph Heitman
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

10.  Projecting global occurrence of Cryptococcus gattii.

Authors:  Deborah J Springer; Vishnu Chaturvedi
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.